WINTON GROUP Ltd Acquires New Position in Oracle Corporation $ORCL

WINTON GROUP Ltd acquired a new stake in Oracle Corporation (NYSE:ORCL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 4,800 shares of the enterprise software provider’s stock, valued at approximately $703,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Sherman Asset Management Inc. boosted its holdings in shares of Oracle by 5.5% in the first quarter. Sherman Asset Management Inc. now owns 1,054 shares of the enterprise software provider’s stock valued at $155,000 after purchasing an additional 55 shares during the period. Southern Capital Advisors LLC increased its holdings in Oracle by 1.3% during the 1st quarter. Southern Capital Advisors LLC now owns 4,446 shares of the enterprise software provider’s stock worth $654,000 after purchasing an additional 57 shares during the period. Global Financial Private Client LLC increased its holdings in Oracle by 0.8% during the 1st quarter. Global Financial Private Client LLC now owns 7,836 shares of the enterprise software provider’s stock worth $1,153,000 after purchasing an additional 59 shares during the period. Key Financial Inc raised its position in Oracle by 0.4% during the 1st quarter. Key Financial Inc now owns 14,203 shares of the enterprise software provider’s stock valued at $2,089,000 after purchasing an additional 62 shares in the last quarter. Finally, Gould Asset Management LLC CA lifted its holdings in shares of Oracle by 2.0% in the 1st quarter. Gould Asset Management LLC CA now owns 3,172 shares of the enterprise software provider’s stock worth $467,000 after buying an additional 62 shares during the period. 42.44% of the stock is currently owned by institutional investors.

Oracle Price Performance

Shares of NYSE ORCL opened at $144.48 on Tuesday. Oracle Corporation has a fifty-two week low of $114.50 and a fifty-two week high of $329.50. The company has a market cap of $416.18 billion, a PE ratio of 22.65, a P/E/G ratio of 1.10 and a beta of 1.74. The company has a debt-to-equity ratio of 1.75, a quick ratio of 1.12 and a current ratio of 1.17. The business has a 50-day simple moving average of $141.09 and a two-hundred day simple moving average of $160.51.

Oracle (NYSE:ORCL) last announced its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.18. The firm had revenue of $19.34 billion for the quarter, compared to analyst estimates of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 47.43%. The business’s quarterly revenue was up 29.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, equities analysts expect that Oracle Corporation will post 6.6 EPS for the current fiscal year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 23rd. Investors of record on Friday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, October 9th. Oracle’s dividend payout ratio (DPR) is currently 31.35%.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle reported revenue of approximately $19.3 billion, up 30% year over year, while adjusted earnings per share of $1.92 exceeded the $1.74 analyst consensus. Cloud revenue rose 62% to $11.6 billion, and strong AI demand contributed to a large remaining performance obligation backlog. Oracle Has the Backlog. Wall Street Wants the Cash
• Positive Sentiment: Oracle Health launched its Clinical AI Agent for U.S. hospitals, adding a new commercial application for its AI technology and potentially supporting long-term healthcare software growth. Oracle Health Clinical AI Agent
• Positive Sentiment: Larry Ellison canceled a planned Rule 10b5-1 sale of up to 50 million ORCL shares, valued at roughly $7.5 billion. No shares were sold, removing a potential source of selling pressure. Analysts including Argus and Barclays remain constructive, with price targets well above the current trading level. Ellison Abandons Planned Stock Sale
• Neutral Sentiment: The canceled insider sale is not a company buyback or fresh investment; therefore, its impact is mainly the removal of possible supply rather than evidence of improved cash flow or corporate capital allocation. Oracle Falls Despite Ellison Scrapping Sale
• Negative Sentiment: Oracle reportedly began another round of layoffs while spending heavily on data centers and AI infrastructure. Higher-than-expected restructuring costs are raising concerns that management is cutting jobs to help fund an increasingly debt-heavy expansion. Oracle Begins a New Round of Layoffs
• Negative Sentiment: Investors remain worried about Oracle’s planned capital expenditures, cash burn, leverage and the time required for AI spending to translate into free cash flow. Comparisons with NVIDIA also highlight Oracle’s lower returns and higher leverage. Why Is Oracle Stock Falling?

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. KeyCorp set a $285.00 price target on Oracle in a research note on Friday. Guggenheim reaffirmed a “buy” rating and issued a $400.00 price objective on shares of Oracle in a research note on Tuesday, September 8th. Mizuho set a $320.00 target price on shares of Oracle in a report on Wednesday, June 3rd. Piper Sandler raised their target price on shares of Oracle from $210.00 to $225.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Finally, Weiss Ratings lowered shares of Oracle from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, July 20th. Two analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Oracle presently has a consensus rating of “Moderate Buy” and an average target price of $252.58.

Insider Transactions at Oracle

In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the transaction, the insider directly owned 400,000 shares of the company’s stock, valued at $63,664,000. The trade was a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company’s stock.

Oracle Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.